By

Scientists at The Scripps Research Institute (TSRI) have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing...

By

Viamet Pharmaceuticals announced Thursday that VT-1129, a potent and selective, oral, antifungal agent, has been granted orphan drug designation by the U.S. Food & Drug Administration (FDA) for the...

By

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever...

By

The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

By

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive...

By

The common macrolide antibiotic, clarithromycin, has been linked to an increase in cardiac deaths, according to researchers at Statens Serum Institut’s Department of Epidemiology Research in Copenhagen. In...

By

Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, has announced the completion of enrollment in...

By

The U.S. Food and Drug Administration is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. Since the outbreak of the Ebola virus in West Africa, the FDA...

By

The Drugs for Neglected Diseases initiative (DNDi) announced Tuesday at the International Congress of Parasitology (ICOPA), the launch of a Phase II drug trial to test fexinidazole, a drug shelved in the...

By

PRESS RELEASE Today, at the Wurtsboro Open Ridge Space in Bloomingburg, U.S. Senator Charles E. Schumer urged the federal Food and Drug Administration (FDA) to investigate and proactively address a potential...